David J. Arthur

Insider Reports History

Entity
Individual
Location
2450 Holcome Blvd., Suite J 608, Houston, TX
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Arthur:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Salarius Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (right to buy) 20.5K Apr 11, 2024 Direct

Insider Reports Filed by David J. Arthur

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLRX Salarius Pharmaceuticals, Inc. Apr 11, 2024 1 $0 4 Apr 12, 2024 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Nov 3, 2022 1 $4.67K 4/A Dec 12, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Nov 3, 2022 1 $17.3K 4/A Nov 8, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. May 26, 2022 5 $7.98K 4 May 31, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. May 3, 2022 1 $1.86K 4 May 5, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Mar 3, 2022 1 $54.5K 4 Mar 9, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Jan 20, 2022 1 $0 4 Jan 21, 2022 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Nov 3, 2021 1 $5.7K 4 Nov 5, 2021 Chief Executive Officer, Director
SLRX Salarius Pharmaceuticals, Inc. Aug 17, 2021 2 $3.58K 4 Aug 17, 2021 Chief Executive Officer, Director